- 同
- IVIG, IGIV, Gamimune, Sandoglobulin
- 関
- Intravenous immunoglobulin
English Journal
- [Kawasaki disease: What you need to know].
- Bajolle F, Laux D.SourceUniversité Paris-Descartes, centre de référence malformations cardiaques congénitales Complexes - M3C, Sorbonne Paris-Cité, Paris, France; Service de cardiologie pédiatrique, hôpital Necker-Enfants-Malades, centre de référence M3C-Necker, AP-HP, 149, rue de Sèvres, 75015 Paris, France. Electronic address: fanny.bajolle@nck.aphp.fr.
- Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie.Arch Pediatr.2012 Nov;19(11):1264-8. doi: 10.1016/j.arcped.2012.07.005. Epub 2012 Aug 24.
- Kawasaki disease (KD) is an acute systemic vasculitis syndrome occurring mostly in children younger than 5 years of age. Especially young infants (<1 year) have an increased risk of coronary artery lesions (CAL). Whereas the etiology of KD is still unknown, progress in treatment during its acute
- PMID 22921712
- Specific cell tropism and neutralization of human parechovirus types 1 and 3: implications for pathogenesis and therapy development.
- Westerhuis BM, Koen G, Wildenbeest JG, Pajkrt D, de Jong MD, Benschop KS, Wolthers KC.SourceDepartment of Medical Microbiology, Laboratory of Clinical Virology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands.
- The Journal of general virology.J Gen Virol.2012 Nov;93(Pt 11):2363-70. doi: 10.1099/vir.0.043323-0. Epub 2012 Jul 25.
- Human parechoviruses (HPeVs) are picornaviruses frequently infecting humans. While HPeV1 is associated with mild disease, HPeV3 is the cause of neonatal sepsis and meningitis. To test whether in vitro replication kinetics of HPeV1 and HPeV3 could be related to pathogenicity, HPeV1 and HPeV3 strains
- PMID 22837420
Japanese Journal
- Electrophysiological classification of Guillain-Barre syndrome : clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group
- Ann Neurol 44, 780-788, 1998
- NAID 30008836282
- Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre sydrome
- Lancet 9047, 225-230, 1997
- NAID 30005707048
- randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome
- Lancet 349, 225-230, 1997
- NAID 10011222227
Related Links
- Sandoglobulin® A proprietary human immune globulin, see there. ... Findings from a second observational study examined 35 patients receiving intravenous replacement therapy who were switched from Sandoglobulin NF liquid (12% ...
- Sandoglobulin intravenous is a sterilized solution made from human plasma. It contains the antibodies to help your body protect itself against infection from various diseases. ... Generic Name: immune globulin (intravenous) (IGIV) (im ...
Related Pictures
